J

Johnson & Johnson

Makes prescription drugs and medical devices

Communications Senior Manager - Core Capabilities HUB

PR & CommunicationsConfirmed live in the last 24 hours
Full-timeChiyoda City, Tokyo, JapanNo salary listed

About the Job

Requirements

  • A bachelor's degree is required.
  • A minimum of 8–12 years of experience in communications, public affairs, or related roles within complex, matrixed organizations is required.
  • A clear understanding of the Japan biopharmaceutical environment, including commercialization, policy, reputational risk, and stakeholder dynamics, is required.
  • The ability to translate global strategy into local execution with discipline and impact is required.
  • Experience driving operational excellence, governance, and change in large, distributed teams is required.
  • Executive presence and the ability to influence senior leaders and operate as a trusted advisor are required.

Responsibilities

  • Lead Japan HUB strategy and execution by translating global HUB vision, governance, and capability standards into local operating models, ways of working, and delivery plans.
  • Drive adoption of HUB capabilities and alignment with enterprise and Innovative Medicine priorities.
  • Focus HUB activities on high-value commercial and reputational opportunities in Japan.
  • Steward core CPA capabilities in Japan, including digital and social platforms; media and issues management; results, measurement, and analytics; internal communications enablement and self-service models; executive communications support; and brand governance and operational systems.
  • Ensure consistent, high-quality deployment of capabilities in alignment with global standards.
  • Partner with the Senior Director, Communications & Public Affairs, Japan, and local Therapeutic Area Communications leads to align HUB resources with business priorities and critical moments.
  • Support integrated planning and execution across launches, data readouts, congresses, and key issues.
  • Act as a strategic partner to ensure communications capabilities drive business impact and reputation outcomes.
  • Ensure consistent application of enterprise governance, compliance, and risk management practices across communications activities in Japan.
  • Establish and reinforce processes, standards, and ways of working aligned with the HUB model.
  • Drive operational discipline, scalability, and efficiency across communication executions.
  • Oversee implementation of measurement and performance analytics in alignment with global frameworks.
  • Partner with global teams to demonstrate impact, inform decision-making, and optimize resource allocation.
  • Identify opportunities for continuous improvement and capability enhancement across the HUB.
  • Enable flexible resourcing and rapid execution to support priority business moments.
  • Coordinate with global and regional HUB teams to ensure access to appropriate expertise and tools.
  • Support efficient scaling of capabilities across priority initiatives.
  • Act as the primary liaison between Japan and Global HUB, ensuring two-way exchange of insights, best practices, and feedback.
  • Contribute to global capability evolution by sharing Japan market insights, needs, and lessons learned.
  • Ensure alignment across global, regional, and local teams.

Desired Qualifications

  • An advanced degree in Communications, Journalism, Business, Public Policy, or a related field is preferred.
  • Experience working in or closely with global priority markets, particularly Japan, is preferred.
  • Exposure to enterprise or center-of-excellence models within communications or public affairs is preferred.
  • Experience partnering with Digital, Technology, Analytics, or Enterprise Communications functions is preferred.

About the Company

Johnson & Johnson

Makes prescription drugs and medical devices

Johnson & Johnson develops prescription medicines and makes medical devices for hospitals, and unlike most big drugmakers, it runs both businesses under one roof. In 2015, its Darzalex became the first antibody drug approved for multiple myeloma, a blood cancer. Its medicines treat cancer, immune diseases such as psoriasis, and mental illnesses such as depression, and patented drugs bring in most of its sales. Its MedTech unit makes heart pumps, catheters that treat irregular heartbeats, surgical sutures, and Acuvue contact lenses. It was founded in 1886 to make sterile surgical dressings, is based in New Brunswick, New Jersey, and spun off its consumer brands, such as Tylenol and Band-Aid, as Kenvue in 2023.

Company size
10,001+
Company stage
IPO
Headquarters
New Brunswick, NJ
Founded
1886

Recently Posted Jobs

Explore more opportunities at Johnson & Johnson

See more jobs